Patents Assigned to Triphase Research and Development I Corp.
  • Patent number: 8986971
    Abstract: Growth medium are disclosed for use in fermenting a marine microorganism. The medium comprise Potassium, Calcium, Strontium, Borate and Fluoride at specific concentrations. Alternatively, the growth medium comprises cobalt at specified concentrations or comprises vitamin B12 at specified concentrations. Methods of producing certain desired compound by fermentation of a marine microorganism are also disclosed.
    Type: Grant
    Filed: September 24, 2007
    Date of Patent: March 24, 2015
    Assignee: Triphase Research and Development I Corp.
    Inventors: Kin Sing Lam, Ginger Tsueng
  • Publication number: 20140349965
    Abstract: Disclosed herein are compositions and methods for treating neoplastic diseases. Included are compositions and methods that are effective against multiple myeloma cells resistant to conventional and bortezomib treatment. Furthermore, combination treatment with two different proteosome inhibitors is shown to be synergistic for treating multiple myeloma.
    Type: Application
    Filed: March 25, 2014
    Publication date: November 27, 2014
    Applicants: Dana-Farber Cancer Institute, Inc., Triphase Research and Development I Corp.
    Inventors: Kenneth C. Anderson, Dharminder Chauhan, Michael A. Palladino
  • Patent number: 8722724
    Abstract: Disclosed herein are compositions and methods for treating neoplastic diseases. Included are compositions and methods that are effective against multiple myeloma cells resistant to conventional and bortezomib treatment. Furthermore, combination treatment with two different proteosome inhibitors is shown to be synergistic for treating multiple myeloma.
    Type: Grant
    Filed: July 30, 2008
    Date of Patent: May 13, 2014
    Assignees: Triphase Research and Development I Corp., Dana-Farber Cancer Institute, Inc.
    Inventors: Kenneth C. Anderson, Dharminder Chauhan, Michael A. Palladino